Page last updated: 2024-10-30

loxoprofen and Muscle Pain

loxoprofen has been researched along with Muscle Pain in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Research Excerpts

ExcerptRelevanceReference
"Loxoprofen (LOX) is a nonsteroidal anti-inflammatory drug (NSAID)."6.90Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial. ( Chen, Z; Hu, S; Li, Z; Lin, J; Shao, Z; Shi, Y; Wang, G; Xiao, W; Zhang, Z; Zhao, D; Zheng, Y, 2019)
"Loxoprofen (LOX) is a nonsteroidal anti-inflammatory drug (NSAID)."2.90Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial. ( Chen, Z; Hu, S; Li, Z; Lin, J; Shao, Z; Shi, Y; Wang, G; Xiao, W; Zhang, Z; Zhao, D; Zheng, Y, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, D1
Chen, Z1
Hu, S1
Lin, J1
Shao, Z1
Wang, G1
Xiao, W1
Zheng, Y1
Zhang, Z1
Shi, Y1
Li, Z1

Trials

1 trial available for loxoprofen and Muscle Pain

ArticleYear
Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial.
    Clinical drug investigation, 2019, Volume: 39, Issue:4

    Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; China; Double-Blind Meth

2019